NCT06473844View on ClinicalTrials.gov

Efficacy of SGLT2 Inhibitors in Adults With Sepsis

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 5, 2025

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
SepsisInflammationSGLT2 InhibitorsCritically IllOrgan Dysfunction Syndrome
Interventions
DRUG

Empagliflozin 10 MG

Empagliflozin 10mg once daily from recruitment to hospital discharge

DRUG

Placebo

Placebo single tablet once daily from recruitment to hospital discharge

Trial Locations (3)

0000

NOT_YET_RECRUITING

4/F Main Clinical Block and Trauma Centre, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, Hong Kong

RECRUITING

Adult Intensive Care Unit, Queen Mary Hospital, 102 Pok Fu Lam Road, Hong Kong, Hong Kong

00

RECRUITING

The University of Hong Kong, Hong Kong

All Listed Sponsors
collaborator

Chinese University of Hong Kong

OTHER

lead

Hospital Authority, Hong Kong

OTHER_GOV